Roche's Combination of Innovation and Diversification Warrant a Wide Moat
We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare giant is uniquely positioned to guide global healthcare toward a safer, more personalized, and more cost-effective future. Strong information sharing continues between Genentech and Roche researchers, boosting research and development productivity and personalized medicine offerings that leverage Roche's diagnostic expertise and leadership in artificial intelligence.
United States